Demystifying Pharma Partnerships: A Conversation with Industry Leaders

Join us for an engaging discussion on navigating pharmaceutical partnerships in healthcare innovation! 🌟

Bringing a novel healthcare innovation to market often requires strategic partnerships with pharmaceutical companies. Many founders and emerging biotech leaders find this process challenging. Our panel of experienced industry leaders will share insights on:

• How pharma partnerships are formed 🤝
• What large pharmaceutical organizations seek in collaborators 🔍
• Strategies for startups to position themselves for successful engagement 🚀

The conversation will cover partnership strategies across the innovation lifecycle, including:

• Early-stage research collaborations
• Licensing opportunities
• Co-development and commercialization
• Strategic investments

Panelists will also address common misconceptions, key diligence considerations, critical negotiation points, and practical advice for founders looking to build meaningful relationships with pharma partners.

Whether you're a biotech founder, investor, scientist, or ecosystem partner, this session will provide valuable insights into the evolving pharma partnership landscape and actionable guidance for turning scientific innovation into impactful collaborations.

Moderator:
Jun Deng, PhD
(Executive Director, Startup Life Sciences and Healthcare Banking, JPMorgan)

Panelists:
Juan Cueva, PhD, MBA
(Senior Director, Search & Evaluation, Johnson & Johnson)
Vanessa Braunstein
(Senior Director, TuneLab AI Drug Discovery Platform, Eli Lilly & Co)
Caitlyn Miller, PhD
(CEO, TwoStep Therapeutics)

Agenda:

• 11:30 AM–12:00 PM – Lunch & Networking 🍽️
• 12:00 PM–12:05 PM – Sponsor Welcome
• 12:05 PM–12:45 PM – Panel Discussion
• 12:45 PM–1:30 PM – Audience Q&A and Networking

Location:
1030 Brittan Ave, San Carlos, CA 94070, USA

Sponsors:
J.P. Morgan, MBC Biolabs, Paul Hastings, Withum